FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214565523> ?p ?o ?g. }

• W4214565523 endingPage "661" @default.
• W4214565523 startingPage "654" @default.
• W4214565523 abstract "Patients with peripheral artery disease (PAD) are an underrecognised group with significant thrombotic risk. This risk is modifiable with the use of aggressive secondary preventative efforts, including optimisation of antithrombotic therapy. Appropriate antithrombotic selection for patients with PAD requires appropriate assessment of thrombotic and bleeding risk. Recent Canadian guidelines have recommended dual pathway therapy initiation for stable PAD and post-revascularisation patients. However, there is ongoing discussion about how to identify PAD patients who stand to benefit most from these therapies while trying to minimise harm from bleeding. Clinical equipoise also persists around questions such as the utility of dual antiplatelet therapy in conjunction with rivaroxaban after high-risk endovascular interventions and the optimal therapy for patients experiencing acute limb ischemia. In patients with chronic PAD and high-risk comorbidities or limb features, or in patients after revascularisation, dual pathway therapy with low-dose rivaroxaban and aspirin has emerged as the only regimen to reduce major adverse cardiovascular and limb events while maintaining an acceptable bleeding profile. After endovascular revascularisation, limited-duration (< 30 days) clopidogrel may be added to rivaroxaban and aspirin in selected high-risk patients at the provider's discretion. After acute limb ischemia, the risk of another vascular event is exceptionally high, but there is no high-quality evidence to guide decision making for intensified antithrombotic therapy. Randomised investigations addressing this question are urgently needed to better serve this high-risk and vulnerable population." @default.
• W4214565523 created "2022-03-02" @default.
• W4214565523 creator A5038939686 @default.
• W4214565523 creator A5058205892 @default.
• W4214565523 creator A5061132830 @default.
• W4214565523 creator A5070860832 @default.
• W4214565523 date "2022-05-01" @default.
• W4214565523 modified "2023-09-29" @default.
• W4214565523 title "Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making" @default.
• W4214565523 cites W2002189205 @default.
• W4214565523 cites W2008836245 @default.
• W4214565523 cites W2019722383 @default.
• W4214565523 cites W2024352468 @default.
• W4214565523 cites W2101872043 @default.
• W4214565523 cites W2110101054 @default.
• W4214565523 cites W2142164422 @default.
• W4214565523 cites W2144471064 @default.
• W4214565523 cites W2164915878 @default.
• W4214565523 cites W2295484744 @default.
• W4214565523 cites W2426190701 @default.
• W4214565523 cites W2430015321 @default.
• W4214565523 cites W2556414715 @default.
• W4214565523 cites W2749380187 @default.
• W4214565523 cites W2770602477 @default.
• W4214565523 cites W2793659838 @default.
• W4214565523 cites W2889325201 @default.
• W4214565523 cites W2953971561 @default.
• W4214565523 cites W2964415308 @default.
• W4214565523 cites W2964481182 @default.
• W4214565523 cites W2966855894 @default.
• W4214565523 cites W2975859535 @default.
• W4214565523 cites W3004033224 @default.
• W4214565523 cites W3013428853 @default.
• W4214565523 cites W3036473193 @default.
• W4214565523 cites W3096554873 @default.
• W4214565523 cites W3111317163 @default.
• W4214565523 cites W311320695 @default.
• W4214565523 cites W3135072998 @default.
• W4214565523 cites W4229536675 @default.
• W4214565523 cites W4236878386 @default.
• W4214565523 cites W3025008623 @default.
• W4214565523 doi "https://doi.org/10.1016/j.cjca.2022.02.018" @default.
• W4214565523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35231554" @default.
• W4214565523 hasPublicationYear "2022" @default.
• W4214565523 type Work @default.
• W4214565523 citedByCount "3" @default.
• W4214565523 countsByYear W42145655232022 @default.
• W4214565523 countsByYear W42145655232023 @default.
• W4214565523 crossrefType "journal-article" @default.
• W4214565523 hasAuthorship W4214565523A5038939686 @default.
• W4214565523 hasAuthorship W4214565523A5058205892 @default.
• W4214565523 hasAuthorship W4214565523A5061132830 @default.
• W4214565523 hasAuthorship W4214565523A5070860832 @default.
• W4214565523 hasConcept C126322002 @default.
• W4214565523 hasConcept C141071460 @default.
• W4214565523 hasConcept C177713679 @default.
• W4214565523 hasConcept C1862650 @default.
• W4214565523 hasConcept C2776301958 @default.
• W4214565523 hasConcept C2777015399 @default.
• W4214565523 hasConcept C2777028646 @default.
• W4214565523 hasConcept C2777466421 @default.
• W4214565523 hasConcept C2777628954 @default.
• W4214565523 hasConcept C2777849778 @default.
• W4214565523 hasConcept C2778661090 @default.
• W4214565523 hasConcept C2779161974 @default.
• W4214565523 hasConcept C2781099653 @default.
• W4214565523 hasConcept C2781413609 @default.
• W4214565523 hasConcept C2908647359 @default.
• W4214565523 hasConcept C2909112448 @default.
• W4214565523 hasConcept C3018348675 @default.
• W4214565523 hasConcept C71924100 @default.
• W4214565523 hasConcept C99454951 @default.
• W4214565523 hasConceptScore W4214565523C126322002 @default.
• W4214565523 hasConceptScore W4214565523C141071460 @default.
• W4214565523 hasConceptScore W4214565523C177713679 @default.
• W4214565523 hasConceptScore W4214565523C1862650 @default.
• W4214565523 hasConceptScore W4214565523C2776301958 @default.
• W4214565523 hasConceptScore W4214565523C2777015399 @default.
• W4214565523 hasConceptScore W4214565523C2777028646 @default.
• W4214565523 hasConceptScore W4214565523C2777466421 @default.
• W4214565523 hasConceptScore W4214565523C2777628954 @default.
• W4214565523 hasConceptScore W4214565523C2777849778 @default.
• W4214565523 hasConceptScore W4214565523C2778661090 @default.
• W4214565523 hasConceptScore W4214565523C2779161974 @default.
• W4214565523 hasConceptScore W4214565523C2781099653 @default.
• W4214565523 hasConceptScore W4214565523C2781413609 @default.
• W4214565523 hasConceptScore W4214565523C2908647359 @default.
• W4214565523 hasConceptScore W4214565523C2909112448 @default.
• W4214565523 hasConceptScore W4214565523C3018348675 @default.
• W4214565523 hasConceptScore W4214565523C71924100 @default.
• W4214565523 hasConceptScore W4214565523C99454951 @default.
• W4214565523 hasFunder F4320307771 @default.
• W4214565523 hasFunder F4320337601 @default.
• W4214565523 hasIssue "5" @default.
• W4214565523 hasLocation W42145655231 @default.
• W4214565523 hasLocation W42145655232 @default.
• W4214565523 hasOpenAccess W4214565523 @default.
• W4214565523 hasPrimaryLocation W42145655231 @default.

• next